Short Term: 2-8°C. Long Term: -20°C. Avoid repeated freezing and thawing.
Introduction
UR-144 is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but with much lower affinity for the psychoactive CB1 receptor.
Antigen Description
Alpha-synuclein recombinant protein expressed from E. coli
Keywords
UR-144; TMCP-018; KM-X1; MN-001; YX-17
Citations
Publication ()
Have you cited DAG-WT196 in a publication? Let us know and earn a reward for your research.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.